Differentiation of malignant from benign focal splenic lesions: added value of diffusion-weighted MRI.

OBJECTIVE The objective of our study was to evaluate the added value of diffusion-weighted imaging (DWI) for distinguishing between malignant and benign focal splenic lesions. MATERIALS AND METHODS This study included 53 patients with 11 malignant and 42 benign splenic lesions who underwent gadoxetic acid-enhanced MRI and DWI. Qualitative and quantitative analyses were conducted for splenic lesions. Two blinded observers evaluated the two image sets--that is, the conventional MR images alone versus the combined conventional MR and DW images--and scored their confidence for malignancy of splenic lesions. The Fisher exact test and Mann-Whitney U test were performed, and diagnostic performance values (ROC curve analysis) were evaluated. RESULTS All malignant lesions showed a progressive hypovascular enhancement pattern, whereas the hypervascular enhancement patterns were shown in only benign lesions (n = 20, 47.6%) (p < 0.05). The mean apparent diffusion coefficient (ADC) of the malignant lesions (0.73 × 10(-3) mm(2)/s) was significantly lower than that of the benign lesions (1.21 × 10(-3) mm(2)/s) (p < 0.001). The addition of DW images to conventional MR images showed a significant improvement for predicting malignant splenic lesions (area under ROC curve [Az] without DW images vs with DW images: 0.774 vs 0.983 for observer 1 and 0.742 vs 0.986 for observer 2) (p < 0.001). In addition, the diagnostic accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of combined conventional MR and DW images were higher than those of conventional MR images alone. CONCLUSION The addition of DWI to conventional MRI improves differentiation of malignant from benign splenic lesions.

[1]  E. Merkle,et al.  A review of MR physics: 3T versus 1.5T. , 2007, Magnetic resonance imaging clinics of North America.

[2]  C. Fìlice,et al.  Ultrasound‐guided fine needle biopsy of the spleen: High clinical efficacy and low risk in a multicenter Italian study , 2001, American journal of hematology.

[3]  K. Ito,et al.  Cystic lymphangioma of the spleen: MR findings with pathologic correlation , 2004, Abdominal Imaging.

[4]  Jacob Cohen,et al.  Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. , 1968 .

[5]  P. Liang,et al.  Real-time contrast-enhanced ultrasound in diagnosing of focal spleen lesions. , 2012, European journal of radiology.

[6]  E. Fishman,et al.  Imaging of the spleen: CT with supplemental MR examination. , 1994, Radiographics : a review publication of the Radiological Society of North America, Inc.

[7]  W. M. Thompson,et al.  From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[8]  R. Semelka,et al.  Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. , 1997, Radiology.

[9]  P. Leander,et al.  Radiology of the spleen , 2001, European Radiology.

[10]  H. Naganuma,et al.  Splenic lymphangioma: US and CT diagnosis and clinical manifestations , 1999, Abdominal Imaging.

[11]  J. Wessling,et al.  Incidentally Detected Splenic Lesions in Ultrasound: Does Contrast-Enhanced Ultrasonography Improve the Differentiation of Benign Hemangioma/Hamartoma from Malignant Lesions? , 2011, Ultraschall in der Medizin.

[12]  K. Horton,et al.  Concurrent Focal Hepatic and Splenic Lesions: A Pictorial Guide to Differential Diagnosis , 2004, Journal of computer assisted tomography.

[13]  A. Stang,et al.  Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography. , 2009, AJR. American journal of roentgenology.

[14]  G. Garlaschi,et al.  CT findings in primary vascular tumors of the spleen. , 1996, AJR. American journal of roentgenology.

[15]  D. Frush,et al.  A pattern-oriented approach to splenic imaging in infants and children. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[16]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[17]  P. Ros,et al.  MRI of focal splenic lesions without and with dynamic gadolinium enhancement. , 2006, AJR. American journal of roentgenology.

[18]  S. Feuerlein,et al.  Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy. , 2009, AJR. American journal of roentgenology.

[19]  R. Semelka,et al.  Enhancement of abdominal organs on hepatic arterial phase: quantitative comparison between 1.5- and 3.0-T magnetic resonance imaging. , 2010, Magnetic resonance imaging.

[20]  R. Halvorsen,et al.  Abdominal and pelvic CT in the HIV-positive population , 2004, Abdominal Imaging.

[21]  T. Nunes,et al.  Isolated metachronous splenic metastasis from renal cell carcinoma after 5 years , 2012, BMJ Case Reports.

[22]  R. Simon,et al.  Radiologic-pathologic conferences of the university of Rochester School of Medicine: inflammatory pseudotumor of the spleen. , 2008, AJR. American journal of roentgenology.

[23]  E. Libson,et al.  Imaging-guided percutaneous splenic biopsy using a 20- or 22-gauge cutting-edge core biopsy needle for the diagnosis of malignant lymphoma. , 2003, AJR. American journal of roentgenology.

[24]  J. Heiken,et al.  MR imaging of the spleen: spectrum of abnormalities. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[25]  C. Bibbolino,et al.  US and CT findings in splenic focal lesions in AIDS. , 2000, Acta radiologica.

[26]  P. Mergo,et al.  Cystic masses of the spleen: radiologic-pathologic correlation. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

[27]  A. Cavallaro,et al.  Laparoscopic splenectomy for splenic hamartoma in elderly patien Case report and review of the literature. , 2012, Annali italiani di chirurgia.

[28]  G. Falk,et al.  Sclerosing Angiomatoid Nodular Transformation (SANT) of the spleen: Case report and review of the literature. , 2012, International journal of surgery case reports.

[29]  C. Garre,et al.  Safety and diagnostic accuracy of percutaneous ultrasound‐guided biopsy of the spleen: A multicenter study , 2009, Journal of clinical ultrasound : JCU.

[30]  F. Lumachi,et al.  Incidentally discovered asymptomatic splenic hamartoma with rapidly expansive growth: a case report. , 2012, In vivo.

[31]  W. Perman,et al.  Magnetic Resonance Measurement of Diffusion in the Abdomen , 2009, Topics in magnetic resonance imaging : TMRI.

[32]  Kewei Li,et al.  Sclerosing angiomatoid nodular transformation of the spleen: report of five cases and review of literature. , 2012, Chinese medical journal.

[33]  A. Capelastegui,et al.  Atypical MRI presentation of a small splenic hamartoma , 1999, European Radiology.

[34]  R Sinkus,et al.  [Diffusion-weighted MR imaging of the liver]. , 2010, Journal de radiologie.

[35]  Takeshi Yoshikawa,et al.  ADC measurement of abdominal organs and lesions using parallel imaging technique. , 2006, AJR. American journal of roentgenology.

[36]  Toshibumi Kinoshita,et al.  Hypointensity on diffusion-weighted MRI of the brain related to T2 shortening and susceptibility effects. , 2003, AJR. American journal of roentgenology.